Meta-Analysis of Efficacy From CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients

• Published in: Frontiers in oncology Vol. 12; p. 876098
• Main Authors: Xu, Li, Yan, Xin, Ding, Weiyue
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 28.04.2022
• Subjects: cytotoxic T-lymphocyte-associated protein 4; immune checkpoint inhibitors; meta-analysis; Oncology; overall survival; programmed cell death 1; progression-free survival; programmed cell death 1; cytotoxic T-lymphocyte-associated protein 4; progression-free survival; meta-analysis; overall survival; programmed death ligand 1; immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) have been approved to prolong overall survival (OS), compared to other treatments. However, the recent studies reported consistent and inconsistent results. Hence, we conducted this meta-analysis to evaluate the efficacy of ICIs. The articles were identified by se...